“Epidemiology of Short QT Interval in Phase I of Kherameh Cohort Study: A Population-based Study on 4,363 Subjects in Southern Iran”

Author(s):  
Mohammad Hossein Nikoo ◽  
Alireza Heiran ◽  
Fardin Mashayekh ◽  
Abbas Rezaianzadeh ◽  
Abbas Shiravani ◽  
...  

Abstract Aims: Short QT-interval is a condition that bear the suspicion of short QT syndrome (SQTS). SQTS is known to increase risk of life-threatening arrythmias and sudden cardiac death (SCD). Due to the insufficient population-based studies and use of various QT cut-off values it accounts for as an undiagnosed condition. In this study, we sought for prevalence of short QT interval in Kherameh cohort study, one of the southern sectors of the Prospective Epidemiological Research Studies in Iran (PERSIAN).Methods: Data of 4,363 adult subjects were analyzed from phase 1 of the cohort during 2014-2017. The corrected QT (QTc) intervals were calculated and electrocardiograms (ECGs) with QTc of less than 370 milliseconds (msec) were reanalyzed for bradycardia, early repolarization, atrial fibrillation (AF), arrhythmias, and other electrical conduction abnormalities. Results: Seventy-two subjects (1.65%) had a QTc of less than 370msec (mean QTc of 360.72±11.72). A male predominance and a lower mean heart rate observed in SQTS susceptible group (M/F of 1/0.26 vs. 1/1.145, p-value<0.0001; 58.389±9.787 vs. 70.899±11.775; p-value<0.0001) compare to the subjects with normal QTc. At least, 2 subjects with high-probability SQTS and 3 with intermediate-probability SQTS identified. The frequency of AF, syncope, bradycardia, early repolarization, low voltage ECG, and infantile SCD in first- and second-degree relatives were 16.67, 4.17, 33.33, 11.11, 6.94, 11.11%, respectively.Conclusion: The prevalence of short QT interval in our cohort was in line with previous studies. The higher proportions of cardiac symptoms, familial SCDs and ECG derived specific findings amongst SQTS-susceptible index persons than non-short QT interval normal population might implicate in gene study and family screening.

PLoS Medicine ◽  
2010 ◽  
Vol 7 (7) ◽  
pp. e1000314 ◽  
Author(s):  
Moritz F. Sinner ◽  
Wibke Reinhard ◽  
Martina Müller ◽  
Britt-Maria Beckmann ◽  
Eimo Martens ◽  
...  

2020 ◽  
Author(s):  
songkeat yodteerug ◽  
Prin Vathesatogkit ◽  
Pattara Rattanawong ◽  
Tachapong Ngarmukos ◽  
Sirin Apiyasawat ◽  
...  

Author(s):  
Tyrone G. Harrison ◽  
Shannon M. Ruzycki ◽  
Matthew T. James ◽  
Paul E. Ronksley ◽  
Kelly B. Zarnke ◽  
...  

2021 ◽  
Vol 184 (1) ◽  
pp. 19-28
Author(s):  
Alexander A Leung ◽  
Janice L Pasieka ◽  
Martin D Hyrcza ◽  
Danièle Pacaud ◽  
Yuan Dong ◽  
...  

Objective Despite the significant morbidity and mortality associated with pheochromocytoma and paraganglioma, little is known about their epidemiology. The primary objective was to determine the incidence of pheochromocytoma and paraganglioma in an ethnically diverse population. A secondary objective was to develop and validate algorithms for case detection using laboratory and administrative data. Design Population-based cohort study in Alberta, Canada from 2012 to 2019. Methods Patients with pheochromocytoma or paraganglioma were identified using linked administrative databases and clinical records. Annual incidence rates per 100 000 people were calculated and stratified according to age and sex. Algorithms to identify pheochromocytoma and paraganglioma, based on laboratory and administrative data, were evaluated. Results A total of 239 patients with pheochromocytoma or paraganglioma (collectively with 251 tumors) were identified from a population of 5 196 368 people over a period of 7 years. The overall incidence of pheochromocytoma or paraganglioma was 0.66 cases per 100 000 people per year. The frequency of pheochromocytoma and paraganglioma increased with age and was highest in individuals aged 60–79 years (8.85 and 14.68 cases per 100 000 people per year for males and females, respectively). An algorithm based on laboratory data (metanephrine >two-fold or normetanephrine >three-fold higher than the upper limit of normal) closely approximated the true frequency of pheochromocytoma and paraganglioma with an estimated incidence of 0.54 cases per 100 000 people per year. Conslusion The incidence of pheochromocytoma and paraganglioma in an unselected population of western Canada was unexpectedly higher than rates reported from other areas of the world.


2017 ◽  
Author(s):  
Bruce Wolffenbuttel ◽  
Hanneke Wouters ◽  
Sandra Slagter ◽  
Waateringe Robert van ◽  
Vliet-Ostaptchouk Jana van ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document